MMPs in the central nervous system: where the good guys go bad.
about
Matrix metalloproteinases in neural development: a phylogenetically diverse perspectiveImplications of MMP9 for Blood Brain Barrier Disruption and Hemorrhagic Transformation Following Ischemic StrokeCurbing Inflammation in Multiple Sclerosis and Endometriosis: Should Mast Cells Be Targeted?Diverse impact of acute and long-term extracellular proteolytic activity on plasticity of neuronal excitabilityMatrix metalloproteinases and minocycline: therapeutic avenues for fragile X syndrome.The significance of matrix metalloproteinases in the immunopathogenesis and treatment of multiple sclerosisEarly Gelatinase Activity Is Not a Determinant of Long-Term Recovery after Traumatic Brain Injury in the Immature MouseBiochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): the next decadeRole of platelets in neuroinflammation: a wide-angle perspectiveInhibition of MMP-2 but not MMP-9 influences inner ear spiral ganglion neurons in vitro.Contributions of matrix metalloproteinases to neural plasticity, habituation, associative learning and drug addiction.Differential expression of Cathepsin S and X in the spinal cord of a rat neuropathic pain modelOverexpression of matrix metalloproteinase-9 (MMP-9) rescues insulin-mediated impairment in the 5XFAD model of Alzheimer's diseaseIncreased cerebral expressions of MMPs, CLDN5, OCLN, ZO1 and AQPs are associated with brain edema following fatal heat stroke.The anti-inflammatory role of tissue inhibitor of metalloproteinase-2 in lipopolysaccharide-stimulated microgliaExtracellular matrix regulation of inflammation in the healthy and injured spinal cordCleavage of osteopontin by matrix metalloproteinase-12 modulates experimental autoimmune encephalomyelitis disease in C57BL/6 mice.Matrix metalloproteinase-12 deficiency ameliorates the clinical course and demyelination in Theiler's murine encephalomyelitis.Comparison of the Effects of Matrix Metalloproteinase Inhibitors on TNF-α Release from Activated Microglia and TNF-α Converting Enzyme ActivityHyperphagia and leptin resistance in tissue inhibitor of metalloproteinase-2 deficient mice.Matrix metalloproteinases, synaptic injury, and multiple sclerosisMetzincin proteases and their inhibitors: foes or friends in nervous system physiology?Role of matrix metalloproteinases and therapeutic benefits of their inhibition in spinal cord injury.Hypoxia-ischemia or excitotoxin-induced tissue plasminogen activator- dependent gelatinase activation in mice neonate brain microvessels.Matrix metalloproteinase (MMP)-9 induced by Wnt signaling increases the proliferation and migration of embryonic neural stem cells at low O2 levels.A dual role for microglia in promoting tissue inhibitor of metalloproteinase (TIMP) expression in glial cells in response to neuroinflammatory stimuliKaempferol acts through mitogen-activated protein kinases and protein kinase B/AKT to elicit protection in a model of neuroinflammation in BV2 microglial cellsLonicera japonica THUNB. Extract Inhibits Lipopolysaccharide-Stimulated Inflammatory Responses by Suppressing NF-κB Signaling in BV-2 Microglial Cellsβ-Lapachone suppresses neuroinflammation by modulating the expression of cytokines and matrix metalloproteinases in activated microgliaMatrix metalloproteinases in the mouse retina: a comparative study of expression patterns and MMP antibodiesSpinal matrix metalloproteinase 3 mediates inflammatory hyperalgesia via a tumor necrosis factor-dependent mechanism.Matrix metalloproteinase-9 and -2 enhance the ligand sensitivity of photoreceptor cyclic nucleotide-gated channels.Differential inhibition of activity, activation and gene expression of MMP-9 in THP-1 cells by azithromycin and minocycline versus bortezomib: A comparative studyPsychotropic effects of antimicrobials and immune modulation by psychotropics: implications for neuroimmune disordersTwo classes of matrix metalloproteinases reciprocally regulate synaptogenesis.Matrix metalloproteinase-9 deficiency leads to prolonged foreign body response in the brain associated with increased IL-1beta levels and leakage of the blood-brain barrier.Increased accumulation of regulatory granulocytic myeloid cells in mannose receptor C type 1-deficient mice correlates with protection in a mouse model of neurocysticercosis.Neuroimmunology of central nervous system viral infections: the cells, molecules and mechanisms involved.Matrix metalloproteinase levels in early HIV infection and relation to in vivo brain status.Inhibition of matrix metalloproteinase activity disrupts reconsolidation but not consolidation of a fear memory
P2860
Q26749060-A24E6D26-06AB-4650-BAA5-5E1C6787E510Q26766038-A612DC94-D075-4DE2-9666-77BC48FF6F30Q26778470-D0DCC734-4BDD-4EE8-86F8-964C102EC6EDQ26796239-09C22E34-7CFB-470C-8071-7831F7EC4B4DQ26853083-64C6729E-132A-4FB2-807C-B7754CB217DFQ27009126-A2E491C9-925B-4E85-A3AA-4C59D8AFCEBEQ27340373-2066AD0E-70F4-4B50-8FC3-108DB727AE6EQ28288148-DC6ADAF5-842D-47BD-8596-D3AE9DB8DF55Q28393808-0F7331AD-3700-4D8A-A955-170C288DEC76Q30414848-099593A8-029C-4F6C-AF02-0D7977BD46B8Q30483239-A7A82575-6547-4DCF-A712-8DFC4DB11246Q33359738-02E0422E-E210-4A74-8AD1-4A20C2EADF41Q33677609-05F15037-002E-4E85-82D1-E881F3F665DEQ33686902-2419084E-02B9-4BB2-AA8A-2A9BAB49B542Q33880665-3E2964E9-CA8F-4718-9600-1E4E63C5B991Q33906928-2F6E67A5-D4D3-4FDF-A4DF-280EF80BFA44Q34086999-3FEC80C4-1C1C-4C27-A690-B3E969B63FA9Q34136881-07D8088D-1307-47DC-948E-F5C074A31469Q34360507-330A955C-7FE0-4D40-BE46-BE53B28EF90AQ34590026-B20CE2E9-CDBE-495E-A652-68FEA3858B8FQ34689554-4EB5ECAB-C567-4420-8D34-B28F32D7172AQ34768858-C252D7E3-B36C-4358-9FD9-0F1FFF6FBACCQ34801330-1A7AE483-4A56-4032-A46F-BD67C2429FF4Q34937315-E693991D-D5A9-45D4-B15B-55A17F72F312Q34978937-C10B3F15-738F-48C0-9182-70D12047BD95Q35061225-DBFA676D-BD11-46BE-8884-4AF63B2296A5Q35376097-74FBBC34-14D5-4B7A-99B1-C3C089F8DD2DQ35822089-B9A9B2CD-06AF-43CB-A548-546F8F596624Q35852416-BF5906AE-8B5C-47B2-965C-C8E32E55A0F9Q35880955-85474A31-764D-4819-B41E-59CC7E3ABDBAQ35940473-8438019F-A572-4EF3-A6D4-249AF9944009Q36201572-50C44DD5-63BF-4D94-9C54-957E690B1824Q36331820-7D185C03-8A1C-4C7E-BBA2-8C76E57851AAQ36387362-201E0B90-6658-4F02-8BCE-8161341ADD9AQ36497245-656EE46B-F9E5-4D0F-BBFC-575B78A3BD9BQ36761698-E1AE5DC4-C37C-4360-A19B-F1C61910DD2CQ36804752-F4360665-575E-4E29-A535-536294F02968Q37037317-F886EBF0-B62A-45E5-A465-D4E306F4E8A7Q37283984-E89AB055-DA74-4E3A-B726-7ACAD17871C4Q37286220-753265FA-78B0-48DB-A932-F9108EC2D2D4
P2860
MMPs in the central nervous system: where the good guys go bad.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
MMPs in the central nervous system: where the good guys go bad.
@en
type
label
MMPs in the central nervous system: where the good guys go bad.
@en
prefLabel
MMPs in the central nervous system: where the good guys go bad.
@en
P2093
P1476
MMPs in the central nervous system: where the good guys go bad.
@en
P2093
Lorraine Lau
Smriti M Agrawal
V Wee Yong
P356
10.1016/J.SEMCDB.2007.06.003
P577
2007-06-19T00:00:00Z